1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-82.70%
Both yoy net incomes decline, with CSIQ at -326.10%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-9.28%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
130.81%
SBC growth of 130.81% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
49.14%
Slight usage while CSIQ is negative at -40.12%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
51.86%
AR growth of 51.86% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
76.86%
Inventory growth of 76.86% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
459.92%
AP growth of 459.92% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-131.37%
Both reduce yoy usage, with CSIQ at -40.12%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
86.99%
Some yoy increase while CSIQ is negative at -43.12%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
89.72%
Some CFO growth while CSIQ is negative at -497.50%. John Neff would note a short-term liquidity lead over the competitor.
100.00%
CapEx growth well above CSIQ's 28.06%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Growth well above CSIQ's 12.45%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
100.00%
Investing outflow well above CSIQ's 26.02%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-102.53%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-78.77%
Negative yoy issuance while CSIQ is 100.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.